Background Immune-mediated processes leading to childhood type 1 diabetes may begin in fetal life. We hypothesised that a ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Future success hinges on regulatory trends, affordability, and patient-centric design innovations. Rising diabetes prevalence drives demand ... Minimally invasive and needle-free systems are emerging ...

Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.

The Diabetes Devices Market was valued at US$ 33.4 Billion in 2024 and is projected to reach US$ 64.8 Billion by 2033, growing at a CAGR of 7.7%. The U.S. diabetes devices market is witnessing strong ...

Researchers at BITS Pilani, Hyderabad, have created a low-cost biosensor for rapid metabolite detection in bodily fluids, ...

Global Medical Device Design and Development Services Market is valued approximately at USD 9.13 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.2% over the ...

A major systematic review and meta-analysis found that aspartame has little to no effect on blood glucose, insulin, or ...

Generative AI's potential to bolster business is staggering. According to one 2023 estimate from McKinsey, in the coming ...

Both Fischel and La Bomba Pharmacies have asked their diabetic customers to schedule a free screening as part of a collaborative program where Ainnova will use its cutting-edge AI platform, Vision AI, ...